These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10710672)

  • 1. (-)-sparteine copper(II) diacetate.
    Lee YM; Chung G; Kwon MA; Choi SN
    Acta Crystallogr C; 2000 Jan; 56 (Pt 1)():67-8. PubMed ID: 10710672
    [No Abstract]   [Full Text] [Related]  

  • 2. Mass spectrometry of metal complexes of bis-quinolizidine alkaloids: electron ionization and fast atom bombardment mass spectral study of copper(II) (-)-sparteine and (-)-alpha- isosparteine complexes.
    Jasiewicz B; Wyrzykiewicz E
    Eur J Mass Spectrom (Chichester); 2009; 15(4):487-95. PubMed ID: 19661557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective nitroaldol (Henry) reaction using copper(II) complexes of (-)-sparteine.
    Maheswaran H; Prasanth KL; Krishna GG; Ravikumar K; Sridhar B; Kantam ML
    Chem Commun (Camb); 2006 Oct; (39):4066-8. PubMed ID: 17024250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new catalytic Cu(II)/sparteine oxidant system for beta,beta-phenolic couplings of styrenyl phenols: synthesis of carpanone and unnatural analogs.
    Daniels RN; Fadeyi OO; Lindsley CW
    Org Lett; 2008 Sep; 10(18):4097-100. PubMed ID: 18729467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of (+)-sparteine-like diamines for asymmetric synthesis.
    Dearden MJ; McGrath MJ; O'Brien P
    J Org Chem; 2004 Aug; 69(17):5789-92. PubMed ID: 15307761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine.
    Sindrup SH; Brøsen K; Bjerring P; Arendt-Nielsen L; Larsen U; Angelo HR; Gram LF
    Clin Pharmacol Ther; 1990 Dec; 48(6):686-93. PubMed ID: 2249379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic investigations of the palladium-catalyzed aerobic oxidative kinetic resolution of secondary alcohols using (-)-sparteine.
    Mueller JA; Sigman MS
    J Am Chem Soc; 2003 Jun; 125(23):7005-13. PubMed ID: 12783555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population.
    Griese EU; Asante-Poku S; Ofori-Adjei D; Mikus G; Eichelbaum M
    Pharmacogenetics; 1999 Dec; 9(6):715-23. PubMed ID: 10634134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of organic compounds containing nitrogen with sodium tetraphenylboron. II. Direct titrimetric determination of sparteine sulfate].
    KAITO T; SAITO E
    Eisei Shikenjo Hokoku; 1961 Sep; 79():77-8. PubMed ID: 14453169
    [No Abstract]   [Full Text] [Related]  

  • 10. The crystal structures of the chiral alkyllithium bases [n-BuLi.(-)-sparteine]2 and [Et2O.(i-PrLi)2.(-)-sparteine].
    Strohmann C; Strohfeldt K; Schildbach D
    J Am Chem Soc; 2003 Nov; 125(45):13672-3. PubMed ID: 14599200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple borohydride/GC method for measuring sparteine metabolites in man.
    Inaba T; Vinks A; Otton SV
    Br J Clin Pharmacol; 1986 May; 21(5):473-80. PubMed ID: 3718806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting the sparteine surrogate: development of a resolution route to the (-)-sparteine surrogate.
    Firth JD; O'Brien P; Ferris L
    Org Biomol Chem; 2014 Dec; 12(46):9357-65. PubMed ID: 25297971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for polymorphic oxidation of sparteine in Japanese subjects.
    Ishizaki T; Eichelbaum M; Horai Y; Hashimoto K; Chiba K; Dengler HJ
    Br J Clin Pharmacol; 1987 Apr; 23(4):482-5. PubMed ID: 3580254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacogenetics of sparteine and debrisoquine.
    Inaba T; Vinks A; Otton SV; Kalow W
    Clin Pharmacol Ther; 1983 Mar; 33(3):394-9. PubMed ID: 6825393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optically active (aR)- and (aS)-linear and vaulted biaryl ligands: deracemization versus oxidative dimerization.
    Hu G; Holmes D; Gendhar BF; Wulff WD
    J Am Chem Soc; 2009 Oct; 131(40):14355-64. PubMed ID: 19754056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sparteine oxidation by the human liver: absence of inhibition by mephenytoin.
    Jurima M; Inaba T; Kalow W
    Clin Pharmacol Ther; 1984 Mar; 35(3):426-8. PubMed ID: 6697650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigations on sparteine reinecane as the material for colorimetric semi microdetermination of sparteine].
    WISNIEWSKI W; DZIEDZIANOWICZ W
    Acta Pol Pharm; 1955; 11(Suppl):124-5. PubMed ID: 13248661
    [No Abstract]   [Full Text] [Related]  

  • 18. Pd(II)-catalyzed conversion of styrene derivatives to acetals: impact of (-)-sparteine on regioselectivity.
    Balija AM; Stowers KJ; Schultz MJ; Sigman MS
    Org Lett; 2006 Mar; 8(6):1121-4. PubMed ID: 16524283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantial rise in sparteine metabolic ratio during haloperidol treatment.
    Gram LF; Debruyne D; Caillard V; Boulenger JP; Lacotte J; Moulin M; Zarifian E
    Br J Clin Pharmacol; 1989 Feb; 27(2):272-5. PubMed ID: 2713222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sparteine oxidation polymorphism in Greenlanders living in Denmark.
    Brøsen K
    Br J Clin Pharmacol; 1986 Oct; 22(4):415-9. PubMed ID: 3768256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.